The Safety of Divalproex Sodium Extended Release Tablets in Migraine Prophylaxis: An Open-Label Extension Study in Adolescents
Phase of Trial: Phase III
Latest Information Update: 30 Jul 2007
At a glance
- Drugs Valproate semisodium; Valproic acid
- Indications Migraine
- Focus Adverse reactions
- Sponsors Abbott Laboratories
- 30 Jul 2007 Status changed from in progress to completed.
- 03 Aug 2006 Status change from recruiting to in progress
- 01 Mar 2006 New trial record.